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Handled by Yi XingRecently an article published in Molecular Cell reveals the
mechanism of a nuclear N6-methyladenosine (m6A) reader,
the YTH domain-containing protein 1 (YTHDC1), in regulat-
ing pre-mRNA splicing [1]. Meanwhile, two additional articles
published in Nature and Nature Chemical Biology report the
first transcriptome-wide maps of N1-methyladenosine (m1A)
at high resolution, suggesting a functional role for m1A in
translation regulation [2,3].
m6A reader YTHDC1 in pre-mRNA alternative
splicing
m6A is the most abundant endogenous mRNA modification,
which is conserved across archea, bacteria, and eukaryotes
[4]. Nonetheless, the importance of m6A in mammals had been
underappreciated for about 40 years until the discovery of its
reversibility by an m6A demethylase—fat mass and obesity-
associated protein (FTO) [5] in 2011. Ever since, the widespread
regulatory roles of m6A have been unraveled through the
transcriptome-wide mapping of m6A modification [6,7], thecharacterization of the second m6A demethylase AlkB
homolog 5 (ALKBH5) [8] and three subunits of m6A methyl-
transferase complex (methyltransferase like 3, METTL3;
METTL14; and Wilms tumor 1 associated protein, WTAP)
[9,10], and the functional studies of m6A readers YTH domain
family protein 1 (YTHDF1) and YTHDF2 in humans, which
regulates m6A methylated RNA stability [11] and translational
efficiency [12], respectively. In addition, m6A in primary micro-
RNAs can be recognized by another m6A reader, the hetero-
geneous nuclear ribonucleoproteins A2/B1 (HNRNPA2B1),
which consequently recruits DiGeorge syndrome critical region
8 (DGCR8) and DROSHA complex and promotes the matura-
tion of microRNAs [13,14].
YTHDC1, as reflected by its name, contains the YTH
domain that selectively binds to m6A [15]. Unlike the other
two cytoplasmic m6A binding proteins YTHDF1 and
YTHDF2, YTHDC1 is localized in YT bodies near the nuclear
speckles [16], supporting its association with pre-mRNA splic-
ing. Xiao and colleagues [1] identified several YTHDC1 part-
ners including five trans-acting splicing factors (serine/
arginine-rich splicing factors; SRSF1/3/9/7/10) by tandem-
affinity purification following by mass spectrometric analysis,
suggesting the potential regulatory role of YTHDC1 in pre-
mRNA splicing. To test such possibility, they measured the
alternative splicing (AS) events using RNA-seq data upon
knockdown of YTHDC1 and its potential SRSF partners in
HeLa cells, respectively. Their findings indicate that YTHDC1nces and
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exon skipping; however, silencing of other SRSF proteins
(SRSF1, SRSF7, and SRSF9) has no significant effect on AS
events. Photoactivatable ribonucleoside crosslinking and
immunoprecipitation (PAR-CLIP) sequencing shows that the
targeted regions of YTHDC1, SRSF3, and SRSF10 are
enriched in the coding sequences (CDS) and the 30 untrans-
lated regions (UTR). Through analyzing the targeted exons,
they further confirmed the opposite roles of YTHDC1/SRSF3
and SRSF10 in AS regulation. The change of AS events on the
transcripts targeted by both YTHDC1 and SRSF3 in HeLa
cells with YTHDC1 or SRSF3 silenced shows similar features
with that in METTL3-silenced HeLa cells, suggesting that
YTHDC1 and SRSF3 co-regulates AS events in an m6A-
dependent manner.
Next, the authors set out to validate the interaction of
YTHDC1 with either SRSF3 or SRSF10. PAR-CLIP data
show that the YTHDC1 target regions are located closer to
the binding sites of SRSF3 than those of SRSF10. In vivo
and in vitro co-immunoprecipitation assay verifies that
YTHDC1 directly interacts with SRSF3 and SRSF10 through
the N-terminal of YTHDC1 and C-terminal of SRSF3 or
SRSF10. The different AS events affected by YTHDC1/
SRSF3 and SRSF10 prompts them to speculate that SRSF3
and SRSF10 might competitively bind to YTHDC1. Indeed
they confirm the hypothesis using competing pull-down assays.
The authors then examine whether YTHDC1 regulates local-
ization of SRSF3 and SRSF10. Immunostaining assays show
that silencing of YTHDC1 reduces SRSF3 but increases
SRSF10 in nuclear speckle. Interestingly, this phenomenon
can be rescued by complementation of wild-type YTHDC1,
but not YTHDC1 mutant without m6A binding ability, indi-
cating that YTHDC1 regulates the subcellular localization of
SRSF3 and SRSF10 in an m6A-dependent manner. Further
RNA binding assay shows that YTHDC1 deficiency disrupts
the RNA binding of SRSF3 but enhances that of SRSF10,
which can be complemented by wild-type YTHDC1, but notYTHDC1
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Figure 1 A proposed model of pre-mRNA splicing regulated by YTH
Under the conditions that m6A in pre-mRNA is recognized by YTHDC
conditions that pre-mRNA does not contain m6A or pre-mRNA with
YTHDC1, YTH domain-containing protein 1; SRSF, serine/arginine-an m6A-binding-defective variant. These results indicate that
the impact of YTHDC1 on AS events relies on the presence
of m6A and the binding ability of YTHDC1 to methylated
RNA.
Clearly, the comprehensive analysis presented by Xiao et al.
reveals that m6A reader YTHDC1 facilitates exon inclusion by
recruiting RNA splicing factor SRSF3 but blocking SRSF10
for its access to the binding regions of its target mRNAs
(Figure 1). Indeed, apart from YTHDC1, m6A reader
HNRNPA2B1 [14] and indirect m6A reader HNRNPC [17]
are both involved in RNA splicing. What roles do these pro-
teins play in AS? Are there any other splicing factors regulated
by m6A? Does YTHDC1 play other regulatory role apart from
splicing? These questions warrant further investigations.The reversible and dynamic m1A methylome in
eukaryotic mRNA
m1A, another RNA adenosine methylation modification, has
been identified in total RNA [18], rRNA [19], and tRNA [20]
for decades. m1A modification contains a methyl group on
N1 (hydrogen bond receptor) to form the positive charge and
disturbs Watson–Crick base pairs. Unlike m6A, m1A can cause
both reverse transcription stops and read-throughs accompa-
nied by mismatches. m1A has been shown to affect the struc-
ture and function of tRNA and rRNA [21,22]. However, the
presence and functions of m1A in mRNA remain unknown.
In the two recently-released papers, Dominissini et al. [2]
and Li et al. [3] reported two transcriptome-wide sequencing
methods (termed m1A-seq and m1A-ID-seq, respectively) to
map m1A in mRNA at high resolution (Figure 2). Their work
reveals that m1A is the second reversible and dynamic
modification in eukaryotic mRNA. They firstly enrich
m1A-containing mRNA fragments from human or mouse cell
lines by m1A-specific antibody immunoprecipitation, and then
take advantage of m1A property in reverse transcription toSPSF10
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1, YTHDC1 recruits SRSF3 to promote exon inclusion; under the
m6A is not bound by YTHDC1, SRSF10 facilitates exon skipping.
rich splicing factor.
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Figure 2 Schematic outline of m1A-seq and m1A-ID-seq
In m1A-seq, mismatch rates caused by m1A (untreated sample) and m6A (chemical rearrangement) were compared. In m1A-ID-seq,
cDNA truncations conferred by m1A (untreated sample) were compared to full-length cDNA (demethylation to A). IP, immunopre-
cipitation; RT, reverse transcription.
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groups employ different approaches for locating m1A sites
(Figure 2). As m1A modification can be converted to m6A in
alkaline conditions (Dimroth rearrangement), Dominissini
et al. treated a portion of precipitated m1A-containing mRNA
fragments with alkaline buffer to chemically rearrange m1A to
m6A prior to cDNA synthesis. By comparing mismatch rates
between treated and untreated samples, they located m1A posi-
tion within m1A peaks, in which mutation rates are high in the
treated sample but low in the untreated sample. In this way,
they can achieve m1A sequencing peaks at the resolution of
5–15 nucleotides (conserved m1A sites in rRNA can be
mapped at the resolution of one nucleotide) [2] (Figure 2).
Different from Dominissini et al., Li et al. used Escherichia coli
AlkB protein to demethylate m1A to regular adenosine and
performed cDNA synthesis with AMV reverse transcriptase
to maximally confer cDNA truncations near m1A sites. In this
way, they achieved the m1A map at the resolution of 55
nucleotides by comparing the m1A peak features between the
untreated and treated samples [3] (Figure 2). In fact, both
strategies, based on mutations or truncations, sacrifice the
sequencing signal and lose some sequence information near
the modified sites, which make it difficult to obtain single-base
resolution m1A maps of high quality.
The relative abundance of m1A in mammalian mRNA
is much lower (m1A/A: 0.015%–0.054% in cell lines and
up to 0.16% in tissues) than that of m6A (m6A/A:0.4%–0.6%) [2]. m1A-seq identified 7154 m1A peaks covering
4151 coding and 63 non-coding genes in humans [2], whereas
m1A-ID-seq detected 901 m1A peaks with high confidence in
600 human genes [3]. Both studies show that most of the
identified transcripts contain only one m1A peak. Unlike
m6A peaks that are enriched in the last transcribed exon
[6,7,23,24], m1A peaks are highly enriched within 5’ UTR
and near start codons.
According to the estimation of Dominissini and colleagues
[2], 20% genes contain a single m1A. Through the deep anal-
ysis, they find that m1A is associated with canonical and alter-
native translation initiation sites, as well as the first splice site.
Therefore they presume that the first spicing reaction might
guide m1A deposition. m1A prefers more structured regions
with high GC content and low minimum free energy. It is of
note that m1A level and distribution pattern in mouse embry-
onic fibroblasts (MEFs) and mouse embryonic stem cells
(mESCs) are comparable to those in human cell lines, suggest-
ing an evolutionarily-conserved pattern of m1A methylome.
They also survey the influence of different stress conditions
on m1A, and find that the total level and peak number of
m1A can be reduced by glucose starvation but enhanced by
heat shock, indicating the dynamic feature of m1A under dif-
ferent physiological conditions. Given the close association
of m1A with the translation initiation sites, Dominissini and
colleagues examine whether m1A affects mRNA translation
by using published ribosome profiling and proteomics data.
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ciency and protein levels compared to non-m1A-containing
genes, implying that m1A modification is correlated with ele-
vated translation.
Meanwhile, Li and colleagues [3] studied the m1A dynamics
induced by H2O2 treatment and serum starvation. They pro-
pose that m1A may reside in a prominent motif with a GA-rich
consensus. Similar with the aforementioned Nature paper, they
state that m1A prefers structured sequences with high GC con-
tent. It is notable that ALKBH3 (human ortholog of E. coli
AlkB) is found to be able to demethylate m1A in human
mRNA, indicating that m1A is a reversible modification and
may play an important regulatory role on mRNA.
Collectively, the two studies by Dominissini and his col-
leagues [2] and Li and his colleagues [3] provide the first
map of transcriptome-wide m1A methylome and suggest
new roles for m1A: this reversible modification is enriched
around start codon, dynamically regulated by stress condi-
tions, and correlated with elevated translation. Although
the two m1A-seq techniques discussed here provide m1A
maps with relatively-high resolution compared to m6A-seq
method (at the resolution of 200 nucleotides), a big chal-
lenge is to develop single-base resolution methods for m6A
and for m1A as well. Another challenge is to uncover the
broader biological functions of m6A and m1A modifications.
Future studies will focus on the identification and character-
ization of writer and reader proteins and functional roles of
these two modifications. Given that m6A as an RNA struc-
ture switch affects RNA–protein interaction [17], the RNA
structure changed by m1A modification might also play cer-
tain functions. We expect more investigations to draw a
more comprehensive picture of RNA modification story.Competing interests
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